GSK plc: Jemperli's Head-To-Head Keytruda Win Stops Price Rot
GSK stock has endured a torrid year-to-date - down 21% in a sector that is performing much better than the S&P. Click here to read my analysis of GSK stock.
Source: seekingalpha.com
Page 10 - Evaluate Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Evaluate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Evaluate Pharma Today - Breaking & Trending Today
Biotech Investors: August's Key PDUFA Catalysts You Must Know
Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to ...
Source: businessinsider.com
Billionaire Jeffrey Talpins Just Fled From These 10 Healthcare Stocks
In this article we look at why Billionaire Jeffrey Talpins Just Fled From These 10 Healthcare Stocks.
Source: insidermonkey.com
What Bear Market? These 2 Stocks Are Killing It.
What else do these companies have in store?
Source: fool.com
Biopharma Partnerships The Key To Filling The Life Sciences Innovation Gap
The life sciences industry is facing a significant slowdown due to patent expirations. Many organizations have not established a robust enough...
Source: lifescienceleader.com